{"ANU": {"name": "Dipti Talaulikar", "link": "https://researchers.anu.edu.au/researchers/talaulikar-d", "colleges": "College of Health & Medicine", "email": "dipti.talaulikar@act.gov.au", "phone": "612 6244 2487", "expertise": ["Pathology Excl. Oral Pathology", "Haematology", "Cancer Cell Biology", "Cancer Diagnosis", "Haematological Tumours"], "interest": ["The Haematology Translational Research Unit at the Canberra Hospital is mainly involved with translational research projects in lymphoproliferative disorders including lymphoma and myeloma. Our particular areas of interest lie in1. determining the cellular origin of lymphoma using a combination of sophisticated flow cytometry and cell sorting, genotyping and ultra deep sequencing techniques,\u00a02. etsablishing links between autoimmunity and lymphoma and3. determining mechanisms of spread of lymphoproliferative disorders to extranodal tissues especially the bone marrow.Most of our projects involve work on archived human tissue samples stored at the Haematology Research Tissue Bank."], "biography": "", "project": [], "publication": [{"title": "practical guide to laboratory investigations at diagnosis and follow up in Waldenstrom macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases", "year": "2020", "source": "Pathology, vol. 52, no. 2, pp. 167-178", "authors": ["Dipti Talaulikar"]}, {"title": "Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance", "year": "2019", "source": "British Journal of Haematology, vol. 187, no. 2, pp. 174-184", "authors": ["Wight J", "Yue M", "Keane C", "Dipti Talaulikar"]}, {"title": "Ibrutinib for the treatment of Bing-Neel syndrome: A multicenter study", "year": "2019", "source": "Blood, vol. 133, no. 4, pp. 299-305", "authors": ["Castillo J", "Itchaki G", "Paludo J", "Dipti Talaulikar"]}, {"title": "Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL", "year": "2018", "source": "Blood, vol. 131, no. 16, pp. 1809-1819", "authors": ["Vari F", "Arpon D", "Keane C", "Dipti Talaulikar"]}, {"title": "high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival", "year": "2018", "source": "Oncotarget, vol. 9, no. 34, pp. 23620-23627", "authors": ["Keane C", "Tobin J", "Dipti Talaulikar"]}, {"title": "Plasma cells arise from differentiation of clonal lymphocytes and secrete IGM in Waldenstrom Macroglobulinemia", "year": "2017", "source": "22nd Congress of the European Hematology Association, ed. Jan Cools (Leuven), Ferrata Storti Foundation, Italy, pp. Volume: 102, Supplement 2, pages 569-570", "authors": ["Dipti Talaulikar", "Lim J", "Wang J"]}, {"title": "Role of plasma cells in Waldenstr\u00c3\u00b6m macroglobulinaemia", "year": "2017", "source": "Pathology, vol. 49, no. 4, pp. 337-345pp", "authors": ["El-Ayoubi A", "Wang J", "Hein N", "Dipti Talaulikar"]}, {"title": "The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma", "year": "2017", "source": "Clinical Cancer Research, vol. 23, no. 7, pp. 1820-1828", "authors": ["Keane C", "Gould C", "Jones K", "Dipti Talaulikar"]}, {"title": "Treatment of patients with Waldenstr?m macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group", "year": "2017", "source": "Internal Medicine Journal, vol. 47, no. 1, pp. 35-49", "authors": ["Dipti Talaulikar", "Tam C", "Joshua D"]}, {"title": "Treatment of patients with Waldenstr?m macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group", "year": "2017", "source": "Internal Medicine Journal, vol. 47, no. 1, pp. 35-49", "authors": ["Dipti Talaulikar", "Tam C", "Joshua D"]}, {"title": "Bisphosphonate guidelines for treatment and prevention of myeloma bone disease", "year": "2017", "source": "Internal Medicine Journal, vol. 47, no. 8, pp. 938-951", "authors": ["Lee O", "Horvath N", "Lee C", "Dipti Talaulikar"]}, {"title": "DeepSNVMiner: A sequence analysis tool to detect emergent, rare mutations in subsets of cell populations", "year": "2016", "source": "PeerJ, vol. 4, no. 5, pp. -", "authors": ["Andrews D", "Jeelall Y", "Dipti Talaulikar"]}, {"title": "Delineation of a novel dendritic-like subset in human spleen", "year": "2016", "source": "Cellular and Molecular Immunology, vol. 13, no. 4, pp. 443-450", "authors": ["Petvises S", "Dipti Talaulikar", "O'Neill H"]}, {"title": "Improving conventional prognosticators in diffuse large B cell lymphoma using marker ratios", "year": "2015", "source": "Big Data and Healthcare Analytics 2015, BigData-HISA 2015, ed. K. Barbuto, L. Schaper, K. Vespoor, CEUR-WS.ORG, TBC, pp. -", "authors": ["Le Cao K", "Keane C", "Han E", "Dipti Talaulikar"]}, {"title": "Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: A population-based study", "year": "2015", "source": "The Lancet Haematology, vol. 2, no. 10, pp. E445-E455", "authors": ["Keane C", "Vari F", "Hertzberg M", "Dipti Talaulikar"]}, {"title": "Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: A population-based study", "year": "2015", "source": "The Lancet Haematology, vol. 2, no. 10, pp. E445-E455", "authors": ["Keane C", "Vari F", "Hertzberg M", "Dipti Talaulikar"]}, {"title": "Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: Position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group", "year": "2015", "source": "Internal Medicine Journal, vol. 45, no. 1, pp. 94-105", "authors": ["Quach H", "Joshua D", "Ho J", "Dipti Talaulikar"]}, {"title": "Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group", "year": "2015", "source": "Internal Medicine Journal, vol. 45, no. 4, pp. 371-382", "authors": ["Weber N", "Mollee P", "Augustson B", "Dipti Talaulikar"]}, {"title": "Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group", "year": "2015", "source": "Internal Medicine Journal, vol. 45, no. 3, pp. 335-343", "authors": ["Quach H", "Joshua D", "Ho J", "Dipti Talaulikar"]}, {"title": "Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?", "year": "2014", "source": "Internal Medicine Journal, vol. 44, no. 3, pp. 287-290", "authors": ["Subramaniam K", "Yeung D", "Grimpen F", "Dipti Talaulikar"]}, {"title": "Multiple myeloma: from diagnosis to treatment", "year": "2013", "source": "Australian Family Physician, vol. 42, no. 10, pp. 684-688", "authors": ["Eslick R", "Dipti Talaulikar"]}, {"title": "Utilisation of sFLC assays - how well do we comply with guidelines?", "year": "2013", "source": "International Journal of Laboratory Hematology, vol. 35, no. 2, pp. 200-210", "authors": ["Phillips D", "Dipti Talaulikar", "Hawkins C"]}, {"title": "Precision of Histological Bone Marrow Staging in Follicular Lymphoma and Diffuse Large B-cell Lymphoma", "year": "2012", "source": "Clinical and Investigative Medicine, vol. 35, no. 6, pp. E358-E364", "authors": ["Chen T", "McDonald A", "Shadbolt F", "Dipti Talaulikar"]}, {"title": "Establishment of a conversion factor for the Cepheid GeneXpert BCR-ABL assay", "year": "2012", "source": "Pathology, vol. 44, no. 1, pp. 55-57", "authors": ["McNiven M", "Dipti Talaulikar"]}, {"title": "Novel therapeutic option for orbital atypical lymphoid hyperplasia", "year": "2010", "source": "Clinical and Experimental Ophthalmology, vol. 38, no. 9, pp. 892-894", "authors": ["Dipti Talaulikar", "Tridgell D", "Leong D"]}, {"title": "Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI)", "year": "2009", "source": "Journal of Hematology and Oncology, vol. 2, no. 49, p. 36", "authors": ["Dipti Talaulikar", "Shadbolt F", "Dahlstrom J"]}, {"title": "Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations", "year": "2009", "source": "Pathology, vol. 41, no. 3, pp. 214-222", "authors": ["Dipti Talaulikar", "Dahlstrom J"]}, {"title": "Role of Immunohistochemistry in staging diffuse large B-cell Lymphoma (DLBCL)", "year": "2008", "source": "Journal of Histochemistry and Cytochemistry, vol. 56, no. 10, pp. 893-900", "authors": ["Dipti Talaulikar", "Dahlstrom J", "Shadbolt F"]}, {"title": "DNA amplification from formalin-fixed decalcified paraffin-embedded bone marrow trephine specimens: does the duration of storage matter?", "year": "2008", "source": "Pathology, vol. 40, no. 7, pp. 702-706", "authors": ["Dipti Talaulikar", "Shadbolt F", "McNiven M"]}, {"title": "comparative study of the quality of DNA obtained from fresh frozen and formalin-fixed decalcified paraffin-embedded bone marrow trephine biopsy specimens using two different methods", "year": "2008", "source": "Journal of Clinical Pathology, vol. 61, pp. 119-123", "authors": ["Dipti Talaulikar", "Gray J", "Shadbolt F"]}, {"title": "Lymphocytopenia as a Prognostic Marker for Diffuse Large B Cell Lymphoma", "year": "2008", "source": "Leukemia & Lymphoma, vol. 49, no. 5, pp. 959-964", "authors": ["Dipti Talaulikar", "Choudhury A", "Shadbolt F"]}, {"title": "Bench work and clinical relevance: a new strategy in pathology education", "year": "2008", "source": "Pathology, vol. 40, no. 7, pp. 707-710", "authors": ["Dipti Talaulikar", "Sachse-Akerlind G", "Potter J"]}, {"title": "Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective", "year": "2008", "source": "Histopathology, vol. 52, pp. 340-347", "authors": ["Dipti Talaulikar", "Shadbolt F", "Bell J"]}, {"title": "Immune Thrombocytopenia after Renal Transplantation for IgA Nephropathy", "year": "2007", "source": "Acta Haematologica, vol. 117, pp. 65-67", "authors": ["Dipti Talaulikar", "Falk M", "Dipti Talaulikar"]}, {"title": "Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study", "year": "2007", "source": "Pathology, vol. 39, no. 6, pp. 580-585", "authors": ["Dipti Talaulikar", "Dahlstrom J", "Shadbolt F"]}, {"title": "Health-related quality of life in chronic coagulation disorders", "year": "2006", "source": "Haemophilia, vol. 12, no. 6, pp. 633-642", "authors": ["Dipti Talaulikar", "Shadbolt F", "McDonald A"]}]}, "Microsoft-Academic": [{"title": "ibrutinib for the treatment of bing neel syndrome a multicenter study", "year": 2019, "source": "blood", "authors": [{"name": "jorge j castillo", "affiliation": "harvard university"}, {"name": "gilad itchaki", "affiliation": "harvard university"}, {"name": "gilad itchaki", "affiliation": "rabin medical center"}, {"name": "jonas paludo", "affiliation": "mayo clinic"}, {"name": "marzia varettoni"}, {"name": "christian buske", "affiliation": "university of ulm"}, {"name": "toby a eyre", "affiliation": "churchill hospital"}, {"name": "julio c chavez", "affiliation": "university of south florida"}, {"name": "kenneth h shain", "affiliation": "university of south florida"}, {"name": "samar issa", "affiliation": "middlemore hospital"}, {"name": "m lia palomba", "affiliation": "memorial sloan kettering cancer center"}, {"name": "oren pasvolsky", "affiliation": "rabin medical center"}, {"name": "david simpson", "affiliation": "north shore hospital"}, {"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "constantine s tam", "affiliation": "peter maccallum cancer centre"}, {"name": "alessandra tedeschi"}, {"name": "stephen m ansell", "affiliation": "mayo clinic"}, {"name": "lakshmi nayak", "affiliation": "harvard university"}, {"name": "steven p treon", "affiliation": "harvard university"}], "id": 200071133}, {"title": "immune evasion via pd 1 pd l1 on nk cells and monocyte macrophages is more prominent in hodgkin lymphoma than dlbcl", "year": 2018, "source": "blood", "authors": [{"name": "frank vari", "affiliation": "university of queensland"}, {"name": "david arpon", "affiliation": "university of queensland"}, {"name": "colm keane", "affiliation": "university of queensland"}, {"name": "colm keane", "affiliation": "princess alexandra hospital"}, {"name": "mark hertzberg"}, {"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "dipti talaulikar", "affiliation": "canberra hospital"}, {"name": "sanjiv jain", "affiliation": "canberra hospital"}, {"name": "qingyan cui", "affiliation": "university of queensland"}, {"name": "erica han", "affiliation": "university of queensland"}, {"name": "josh tobin", "affiliation": "university of queensland"}, {"name": "josh tobin", "affiliation": "princess alexandra hospital"}, {"name": "robert bird", "affiliation": "princess alexandra hospital"}, {"name": "donna cross", "affiliation": "princess alexandra hospital"}, {"name": "annette hernandez", "affiliation": "princess alexandra hospital"}, {"name": "clare gould", "affiliation": "university of queensland"}, {"name": "clare gould", "affiliation": "princess alexandra hospital"}, {"name": "simone birch", "affiliation": "princess alexandra hospital"}, {"name": "maher k gandhi", "affiliation": "university of queensland"}, {"name": "maher k gandhi", "affiliation": "princess alexandra hospital"}], "id": 200071133}, {"title": "consensus treatment recommendations from the tenth international workshop for waldenstrom macroglobulinaemia", "year": 2020, "source": "the lancet haematology", "authors": [{"name": "jorge j castillo", "affiliation": "harvard university"}, {"name": "ranjana h advani", "affiliation": "stanford university"}, {"name": "andrew r branagan", "affiliation": "harvard university"}, {"name": "christian buske", "affiliation": "university of ulm"}, {"name": "meletios a dimopoulos", "affiliation": "national and kapodistrian university of athens"}, {"name": "shirley dsa", "affiliation": "university college london hospitals nhs foundation trust"}, {"name": "marie jose kersten", "affiliation": "university of amsterdam"}, {"name": "veronique leblond", "affiliation": "university of paris"}, {"name": "monique c minnema", "affiliation": "utrecht university"}, {"name": "roger g owen", "affiliation": "st james s university hospital"}, {"name": "m lia palomba", "affiliation": "memorial sloan kettering cancer center"}, {"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "alessandra tedeschi"}, {"name": "judith trotman", "affiliation": "university of sydney"}, {"name": "marzia varettoni"}, {"name": "josephine m i vos", "affiliation": "university of amsterdam"}, {"name": "steven p treon", "affiliation": "harvard university"}, {"name": "efstathios kastritis", "affiliation": "national and kapodistrian university of athens"}], "id": 2531671668}, {"title": "consensus statement on the management of waldenstrom macroglobulinemia patients during the covid 19 pandemic", "year": 2020, "source": "", "authors": [{"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "ranjana h advani", "affiliation": "stanford university"}, {"name": "andrew r branagan", "affiliation": "harvard university"}, {"name": "christian buske", "affiliation": "university of ulm"}, {"name": "meletios a dimopoulos", "affiliation": "national and kapodistrian university of athens"}, {"name": "shirley dsa", "affiliation": "university college london hospitals nhs foundation trust"}, {"name": "maria jose kersten", "affiliation": "university of amsterdam"}, {"name": "veronique leblond", "affiliation": "university of paris"}, {"name": "monique c minnema", "affiliation": "utrecht university"}, {"name": "roger g owen", "affiliation": "st james s university hospital"}, {"name": "maria lia palomba", "affiliation": "memorial sloan kettering cancer center"}, {"name": "alessandra tedeschi"}, {"name": "judith trotman", "affiliation": "university of sydney"}, {"name": "marzia varettoni"}, {"name": "josephine m vos"}, {"name": "steven p treon", "affiliation": "harvard university"}, {"name": "efstathios kastritis", "affiliation": "national and kapodistrian university of athens"}, {"name": "jorge j castillo", "affiliation": "harvard university"}]}, {"title": "zanubrutinib for the treatment of myd88 wild type waldenstrom macroglobulinemia a substudy of the phase 3 aspen trial", "year": 2020, "source": "blood advances", "authors": [{"name": "meletios a dimopoulos", "affiliation": "national and kapodistrian university of athens"}, {"name": "ramon garcia sanz"}, {"name": "huipeng lee", "affiliation": "flinders medical centre"}, {"name": "marek trneny", "affiliation": "charles university in prague"}, {"name": "marzia varettoni"}, {"name": "stephen opat", "affiliation": "monash university clayton campus"}, {"name": "shirley dsa", "affiliation": "university college hospital"}, {"name": "roger g owen"}, {"name": "gavin cull", "affiliation": "university of western australia"}, {"name": "gavin cull", "affiliation": "sir charles gairdner hospital"}, {"name": "stephen p mulligan", "affiliation": "royal north shore hospital"}, {"name": "jaroslaw czyz", "affiliation": "nicolaus copernicus university in torun"}, {"name": "jorge j castillo", "affiliation": "harvard university"}, {"name": "marina motta"}, {"name": "tanya siddiqi", "affiliation": "city of hope national medical center"}, {"name": "mercedes gironella mesa"}, {"name": "miquel granell gorrochategui"}, {"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "pier luigi zinzani", "affiliation": "university of bologna"}, {"name": "elham askari"}, {"name": "sebastian grosicki", "affiliation": "medical university of silesia"}, {"name": "albert oriol"}, {"name": "simon rule", "affiliation": "derriford hospital"}, {"name": "janusz kloczko"}, {"name": "alessandra tedeschi"}, {"name": "christian buske"}, {"name": "veronique leblond", "affiliation": "university of paris"}, {"name": "judith trotman", "affiliation": "concord repatriation general hospital"}, {"name": "wai y chan"}, {"name": "jan michel"}, {"name": "jingjing schneider"}, {"name": "ziwen tan"}, {"name": "aileen cohen"}, {"name": "jane huang"}, {"name": "constantine s tam"}], "id": 2764683450}, {"title": "ibrutinib for the treatment of bing neel syndrome a retrospective multicenter study", "year": 2019, "source": "hematological oncology", "authors": [{"name": "jorge j castillo", "affiliation": "harvard university"}, {"name": "gilad itchaki", "affiliation": "rabin medical center"}, {"name": "jonas paludo", "affiliation": "mayo clinic"}, {"name": "marzia varettoni"}, {"name": "christian buske", "affiliation": "university of ulm"}, {"name": "toby a eyre", "affiliation": "churchill hospital"}, {"name": "julio c chavez"}, {"name": "k shain"}, {"name": "samar issa", "affiliation": "middlemore hospital"}, {"name": "lia palomba", "affiliation": "memorial sloan kettering cancer center"}, {"name": "oren pasvolsky", "affiliation": "rabin medical center"}, {"name": "d simpson", "affiliation": "north shore hospital"}, {"name": "dipti talaulikar", "affiliation": "canberra hospital"}, {"name": "constantine s tam", "affiliation": "peter maccallum cancer centre"}, {"name": "alessandra tedeschi"}, {"name": "s m ansell", "affiliation": "mayo clinic"}, {"name": "lakshmi nayak", "affiliation": "harvard university"}, {"name": "steven p treon", "affiliation": "harvard university"}], "id": 23714410}, {"title": "ratios of t cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large b cell lymphoma a population based study", "year": 2015, "source": "the lancet haematology", "authors": [{"name": "colm keane", "affiliation": "griffith university"}, {"name": "colm keane", "affiliation": "university of queensland"}, {"name": "colm keane", "affiliation": "princess alexandra hospital"}, {"name": "frank vari", "affiliation": "university of queensland"}, {"name": "mark p hertzberg"}, {"name": "kimanh le cao", "affiliation": "university of queensland"}, {"name": "michael r green", "affiliation": "eppley institute for research in cancer and allied diseases"}, {"name": "erica han", "affiliation": "university of queensland"}, {"name": "john f seymour", "affiliation": "peter maccallum cancer centre"}, {"name": "rodney j hicks", "affiliation": "peter maccallum cancer centre"}, {"name": "devinder gill", "affiliation": "university of queensland"}, {"name": "devinder gill", "affiliation": "princess alexandra hospital"}, {"name": "pauline crooks", "affiliation": "university of queensland"}, {"name": "clare gould", "affiliation": "university of queensland"}, {"name": "clare gould", "affiliation": "princess alexandra hospital"}, {"name": "kimberley jones", "affiliation": "university of queensland"}, {"name": "lyn r griffiths", "affiliation": "griffith university"}, {"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "dipti talaulikar", "affiliation": "canberra hospital"}, {"name": "sanjiv jain", "affiliation": "canberra hospital"}, {"name": "josh tobin", "affiliation": "australian national university"}, {"name": "maher k gandhi", "affiliation": "university of queensland"}, {"name": "maher k gandhi", "affiliation": "princess alexandra hospital"}], "id": 2531671668}, {"title": "ibrutinib for the treatment of bing neel syndrome", "year": 2018, "source": "blood", "authors": [{"name": "gilad itchaki", "affiliation": "harvard university"}, {"name": "jonas paludo", "affiliation": "mayo clinic"}, {"name": "maria lia palomba", "affiliation": "memorial sloan kettering cancer center"}, {"name": "marzia varettoni", "affiliation": "university of pavia"}, {"name": "dipti talaulikar", "affiliation": "canberra hospital"}, {"name": "julio c chavez"}, {"name": "christian buske", "affiliation": "university of ulm"}, {"name": "alessandra tedeschi"}, {"name": "david simpson", "affiliation": "north shore hospital"}, {"name": "constantine s tam", "affiliation": "st vincent s health system"}, {"name": "samar issa", "affiliation": "middlemore hospital"}, {"name": "stephen m ansell", "affiliation": "mayo clinic"}, {"name": "steven p treon", "affiliation": "harvard university"}, {"name": "jorge j castillo", "affiliation": "harvard university"}], "id": 200071133}, {"title": "bing neel syndrome retrospective australasian experience of a rare treatable complication of waldenstrom macroglobulinaemia lymphoplasmacytic lymphoma", "year": 2018, "source": "blood", "authors": [{"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "dipti talaulikar", "affiliation": "canberra hospital"}, {"name": "tara cochrane"}, {"name": "john gibson", "affiliation": "university of sydney"}, {"name": "john gibson", "affiliation": "royal prince alfred hospital"}, {"name": "nada hamad"}, {"name": "phoebe joy ho", "affiliation": "university of sydney"}, {"name": "phoebe joy ho", "affiliation": "royal prince alfred hospital"}, {"name": "samar issa", "affiliation": "middlemore hospital"}, {"name": "kwok fiona", "affiliation": "westmead hospital"}, {"name": "jun hee lim", "affiliation": "australian national university"}, {"name": "david simpson", "affiliation": "north shore hospital"}, {"name": "constantine s tam", "affiliation": "st vincent s health system"}, {"name": "jorge j castillo", "affiliation": "harvard university"}], "id": 200071133}, {"title": "the t cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive b cell lymphoma", "year": 2017, "source": "clinical cancer research", "authors": [{"name": "colm keane", "affiliation": "university of queensland"}, {"name": "colm keane", "affiliation": "princess alexandra hospital"}, {"name": "clare gould", "affiliation": "university of queensland"}, {"name": "clare gould", "affiliation": "princess alexandra hospital"}, {"name": "kimberley jones", "affiliation": "university of queensland"}, {"name": "david hamm"}, {"name": "dipti talaulikar", "affiliation": "australian national university"}, {"name": "dipti talaulikar", "affiliation": "canberra hospital"}, {"name": "jonathan ellis", "affiliation": "university of queensland"}, {"name": "frank vari", "affiliation": "university of queensland"}, {"name": "simone birch", "affiliation": "princess alexandra hospital"}, {"name": "erica han", "affiliation": "university of queensland"}, {"name": "peter wood", "affiliation": "princess alexandra hospital"}, {"name": "kim anh lecao", "affiliation": "university of queensland"}, {"name": "michael r green", "affiliation": "eppley institute for research in cancer and allied diseases"}, {"name": "pauline crooks", "affiliation": "university of queensland"}, {"name": "sanjiv jain", "affiliation": "canberra hospital"}, {"name": "josh tobin", "affiliation": "university of queensland"}, {"name": "josh tobin", "affiliation": "princess alexandra hospital"}, {"name": "raymond j steptoe", "affiliation": "university of queensland"}, {"name": "maher k gandhi", "affiliation": "university of queensland"}, {"name": "maher k gandhi", "affiliation": "princess alexandra hospital"}], "id": 183149254}], "ANDS-Grants": []}